Sinopharm Group Co. Ltd.

SHTDFOTCHealthcare● Active

$2.30

+$0.01(+0.44%)

Market Cap$7.2B

P/E Ratio—

52W High$2.7

52W Low$2.11

Avg Volume122

Open$2.30

Beta0.45

Net Income Financials Revenue

Sinopharm Group Co. Ltd. (SHTDF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SHTDF · net income · updated Jun 9, 2026

Core profitability metrics

SHTDF · net income · margin · TTM · CAGR

Net income was $6.97B for FY2025 (fiscal year ending 2025-12-31), down 1.1% year-over-year. Net profit margin was 1.2%. Based on available data, Sinopharm Group Co. Ltd. has been profitable since at least 2011.

FY2025 Net Income$6.97B▼ -1.1% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin1.2%$6.97B ÷ $560.33B

YoY Change-1.1%—

5-Year CAGR-0.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · SHTDF net income history · SHTDF profit margin

Annual net income data

SHTDF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$6.97B▼ 1.1%1.2%$560.33B

FY2024$7.05B▼ 22.1%1.2%$584.51B

FY2023$9.05B▲ +6.2%1.5%$596.57B

FY2022$8.53B▲ +9.9%1.5%$552.15B

FY2021$7.76B▲ +7.9%1.5%$521.05B

Net income vs peers (Healthcare)

SHTDF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Sinopharm Group Co. Ltd. (SHTDF) reported net income of $6.97B for FY2025 (fiscal year ending 2025-12-31), down 1.1% year-over-year. The net profit margin was 1.2% — meaning the company kept $0.01 of every dollar of revenue as profit.

Based on available data, Sinopharm Group Co. Ltd. has been profitable since at least 2011. Net income reached a peak of $10.62B in FY2019. Data available for 15 fiscal years.

Sinopharm Group Co. Ltd.'s net profit margin was 1.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Sinopharm Group Co. Ltd. net worth" — the company's market capitalization is a separate figure from SHTDF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SHTDF net income · 5 questions

Sinopharm Group Co. Ltd. is profitable. The company reported net income of $6.97B for FY2025, a net profit margin of 1.2%. Net income was down 1.1% year-over-year. Based on available data, Sinopharm Group Co. Ltd. has been profitable since at least 2011.

is SHTDF profitabledoes SHTDF make a profitSHTDF profitabilitySHTDF profitable company

▸ Source: FMP /income-statement · GAAP · Sinopharm Group Co. Ltd. · Sinopharm Group Co. Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026